# Evaluation of Meningococcal ACWY Immune Response in Children Aged 40 and 60 Months

> **NCT00601731** · PHASE2 · COMPLETED · sponsor: **Novartis Vaccines** · enrollment: 382 (actual)

## Conditions studied

- Meningococcal Disease

## Interventions

- **BIOLOGICAL:** MenACWY-CRM197
- **BIOLOGICAL:** Blood test

## Key facts

- **NCT ID:** NCT00601731
- **Lead sponsor:** Novartis Vaccines
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2010-07
- **Final completion:** 2010-09
- **Target enrollment:** 382 (ACTUAL)
- **Last updated:** 2014-10-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00601731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00601731, "Evaluation of Meningococcal ACWY Immune Response in Children Aged 40 and 60 Months". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00601731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*